Literature DB >> 25261924

Wnt activation affects proliferation, invasiveness and radiosensitivity in medulloblastoma.

Roberta Salaroli1, Alice Ronchi, Francesca Romana Buttarelli, Filippo Cortesi, Valeria Marchese, Elena Della Bella, Cristiano Renna, Caterina Baldi, Felice Giangaspero, Giovanna Cenacchi.   

Abstract

Medulloblastomas (MBs) associated with the Wnt activation represent a subgroup with a favorable prognosis, but it remains unclear whether Wnt activation confers a less aggressive phenotype and/or enhances radiosensitivity. To investigate this issue, we evaluated the biological behavior of an MB cell line, UW228-1, stably transfected with human β-catenin cDNA encoding a nondegradable form of β-catenin (UW-B) in standard culture conditions and after radiation treatment. We evaluated the expression, transcriptional activity, and localization of β-catenin in the stably transfected cells using immunofluorescence and WB. We performed morphological analysis using light and electron microscopy. We then analyzed changes in the invasiveness, growth, and mortality in standard culture conditions and after radiation. We demonstrated that (A) Wnt activation inhibited 97 % of the invasion capability of the cells, (B) the growth of the UW-B cells was statistically significantly lower than that of all the other control cells (p < 0.01), (C) the mortality of irradiated UW-B cells was statistically significantly higher than that of the controls and their nonirradiated counterparts (p < 0.05), and (D) morphological features of neuronal differentiation were observed in the Wnt-activated cells. In tissue samples, the Ki-67 labeling index (LI) was lower in β-catenin-positive samples compared to non-β-catenin positive ones. The Ki-67 LI median (LI = 40) of the nuclear β-catenin-positive tumor samples was lower than that of non-nuclear β-catenin-positive samples (LI = 50), but the difference was not statistically significant. Overall, our data suggest that activation of the Wnt pathway reduces the proliferation and invasion of MBs and increases the tumor's radiosensitivity.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25261924     DOI: 10.1007/s11060-014-1621-0

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  29 in total

Review 1.  Wnt signaling and cancer.

Authors:  P Polakis
Journal:  Genes Dev       Date:  2000-08-01       Impact factor: 11.361

2.  Norcantharidin impairs medulloblastoma growth by inhibition of Wnt/β-catenin signaling.

Authors:  Flora Cimmino; Maria Nunzia Scoppettuolo; Marianeve Carotenuto; Pasqualino De Antonellis; Valeria Di Dato; Gennaro De Vita; Massimo Zollo
Journal:  J Neurooncol       Date:  2011-07-07       Impact factor: 4.130

3.  beta-Catenin status predicts a favorable outcome in childhood medulloblastoma: the United Kingdom Children's Cancer Study Group Brain Tumour Committee.

Authors:  David W Ellison; Olabisi E Onilude; Janet C Lindsey; Meryl E Lusher; Claire L Weston; Roger E Taylor; Andrew D Pearson; Steven C Clifford
Journal:  J Clin Oncol       Date:  2005-11-01       Impact factor: 44.544

4.  Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups.

Authors:  David W Ellison; James Dalton; Mehmet Kocak; Sarah Leigh Nicholson; Charles Fraga; Geoff Neale; Anna M Kenney; Dan J Brat; Arie Perry; William H Yong; Roger E Taylor; Simon Bailey; Steven C Clifford; Richard J Gilbertson
Journal:  Acta Neuropathol       Date:  2011-01-26       Impact factor: 17.088

Review 5.  Molecular diagnostics of CNS embryonal tumors.

Authors:  Stefan M Pfister; Andrey Korshunov; Marcel Kool; Martin Hasselblatt; Charles Eberhart; Michael D Taylor
Journal:  Acta Neuropathol       Date:  2010-09-30       Impact factor: 17.088

Review 6.  A re-evaluation of the "oncogenic" nature of Wnt/beta-catenin signaling in melanoma and other cancers.

Authors:  Olivia M Lucero; David W Dawson; Randall T Moon; Andy J Chien
Journal:  Curr Oncol Rep       Date:  2010-09       Impact factor: 5.075

7.  c-Myc and beta-catenin cooperate with loss of p53 to generate multiple members of the primitive neuroectodermal tumor family in mice.

Authors:  H Momota; A H Shih; M A Edgar; E C Holland
Journal:  Oncogene       Date:  2008-03-31       Impact factor: 9.867

8.  Illegitimate WNT signaling promotes proliferation of multiple myeloma cells.

Authors:  Patrick W B Derksen; Esther Tjin; Helen P Meijer; Melanie D Klok; Harold D MacGillavry; Marinus H J van Oers; Henk M Lokhorst; Andries C Bloem; Hans Clevers; Roel Nusse; Ronald van der Neut; Marcel Spaargaren; Steven T Pals
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-05       Impact factor: 11.205

9.  β-Catenin Signalling in Glioblastoma Multiforme and Glioma-Initiating Cells.

Authors:  Mireia Nager; Deepshikha Bhardwaj; Carles Cantí; Loreta Medina; Pere Nogués; Judit Herreros
Journal:  Chemother Res Pract       Date:  2012-02-12

10.  An investigation of WNT pathway activation and association with survival in central nervous system primitive neuroectodermal tumours (CNS PNET).

Authors:  H A Rogers; S Miller; J Lowe; M-A Brundler; B Coyle; R G Grundy
Journal:  Br J Cancer       Date:  2009-03-17       Impact factor: 7.640

View more
  6 in total

Review 1.  Medulloblastoma: Tumor Biology and Relevance to Treatment and Prognosis Paradigm.

Authors:  Daniel Coluccia; Carlyn Figuereido; Semra Isik; Christian Smith; James T Rutka
Journal:  Curr Neurol Neurosci Rep       Date:  2016-05       Impact factor: 5.081

2.  Molecular characterization of Wnt pathway and function of β-catenin overexpression in medulloblastoma cell lines.

Authors:  Lenisa Geron; Karina Bezerra Salomão; Kleiton Silva Borges; Augusto Faria Andrade; Carolina Alves Pereira Corrêa; Carlos Alberto Scrideli; Luiz Gonzaga Tone
Journal:  Cytotechnology       Date:  2018-10-29       Impact factor: 2.058

3.  WISP1 polymorphisms contribute to platinum-based chemotherapy toxicity in lung cancer patients.

Authors:  Juan Chen; Jiye Yin; Xiangping Li; Ying Wang; Yi Zheng; Chenyue Qian; Ling Xiao; Ting Zou; Zhan Wang; Junyan Liu; Wei Zhang; Honghao Zhou; Zhaoqian Liu
Journal:  Int J Mol Sci       Date:  2014-11-14       Impact factor: 5.923

Review 4.  Radioresistance of Brain Tumors.

Authors:  Kevin Kelley; Jonathan Knisely; Marc Symons; Rosamaria Ruggieri
Journal:  Cancers (Basel)       Date:  2016-03-30       Impact factor: 6.639

5.  Curcumin Affects Gastric Cancer Cell Migration, Invasion and Cytoskeletal Remodeling Through Gli1-β-Catenin.

Authors:  Xiao Zhang; Chenli Zhang; Zhiheng Ren; Fangfang Zhang; Jinyu Xu; Xu Zhang; Haixue Zheng
Journal:  Cancer Manag Res       Date:  2020-05-21       Impact factor: 3.989

Review 6.  Targeting mTOR as a Therapeutic Approach in Medulloblastoma.

Authors:  Juncal Aldaregia; Ainitze Odriozola; Ander Matheu; Idoia Garcia
Journal:  Int J Mol Sci       Date:  2018-06-22       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.